<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients - Bruder, EA - 2015 | Cochrane Library</title> <meta content="Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients - Bruder, EA - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010225.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients - Bruder, EA - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010225.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010225.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients" name="citation_title"/> <meta content="Eric A Bruder" name="citation_author"/> <meta content="Queen's University" name="citation_author_institution"/> <meta content="ebruder1@me.com" name="citation_author_email"/> <meta content="Ian M Ball" name="citation_author"/> <meta content="Western University" name="citation_author_institution"/> <meta content="Stacy Ridi" name="citation_author"/> <meta content="Queen's University" name="citation_author_institution"/> <meta content="William Pickett" name="citation_author"/> <meta content="Queen's University" name="citation_author_institution"/> <meta content="Corinne Hohl" name="citation_author"/> <meta content="University of British Columbia" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD010225.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/01/08" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010225.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010225.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010225.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Critical Illness; *Intubation, Intratracheal; Adrenal Insufficiency [*chemically induced, mortality]; Etomidate [*administration &amp; dosage, *adverse effects]; Health Services Needs and Demand [statistics &amp; numerical data]; Hypnotics and Sedatives [*administration &amp; dosage, *adverse effects]; Intensive Care Units [statistics &amp; numerical data]; Length of Stay; Organ Dysfunction Scores; Randomized Controlled Trials as Topic; Respiration, Artificial [statistics &amp; numerical data]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010225.pub2&amp;doi=10.1002/14651858.CD010225.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WbpyPs9C";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010225\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010225\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","zh_HANS","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010225.pub2",title:"Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients",firstPublishedDate:"Jan 8, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Emergency and Critical Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010225.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010225.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010225.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010225.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010225.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010225.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010225.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010225.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010225.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010225.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5697 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010225.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-sec-0093"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-sec-0082"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/appendices#CD010225-sec-0098"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/table_n/CD010225StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/table_n/CD010225StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information#CD010225-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Eric A Bruder</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information#CD010225-cr-0003">Ian M Ball</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information#CD010225-cr-0004">Stacy Ridi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information#CD010225-cr-0005">William Pickett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information#CD010225-cr-0006">Corinne Hohl</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information/en#CD010225-sec-0110">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 08 January 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010225.pub2">https://doi.org/10.1002/14651858.CD010225.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010225-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010225-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010225-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010225-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010225-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010225-abs-0007">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010225-abs-0001" lang="en"> <section id="CD010225-sec-0001"> <h3 class="title" id="CD010225-sec-0001">Background</h3> <p>The use of etomidate for emergency airway interventions in critically ill patients is very common. In one large registry trial, etomidate was the most commonly used agent for this indication. Etomidate is known to suppress adrenal gland function, but it remains unclear whether or not this adrenal gland dysfunction affects mortality. </p> </section> <section id="CD010225-sec-0002"> <h3 class="title" id="CD010225-sec-0002">Objectives</h3> <p>The primary objective was to assess, in populations of critically ill patients, whether a single induction dose of etomidate for emergency airway intervention affects mortality. </p> <p>The secondary objectives were to address, in populations of critically ill patients, whether a single induction dose of etomidate for emergency airway intervention affects adrenal gland function, organ dysfunction, or health services utilization (as measured by intensive care unit (ICU) length of stay (LOS), duration of mechanical ventilation, or vasopressor requirements). </p> <p>We repeated analyses within subgroups defined by the aetiologies of critical illness, timing of adrenal gland function measurement, and the type of comparator drug used. </p> </section> <section id="CD010225-sec-0003"> <h3 class="title" id="CD010225-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE; CINAHL; EMBASE; LILACS; International Pharmaceutical Abstracts; Web of Science; the Database of Abstracts of Reviews of Effects (DARE); and ISI BIOSIS Citation index<sup>SM</sup> on 8 February 2013. We reran the searches in August 2014. We will deal with any studies of interest when we update the review. </p> <p>We also searched the Scopus database of dissertations and conference proceedings and the US Food and Drug Administration Database. We handsearched major emergency medicine, critical care, and anaesthesiology journals. </p> <p>We handsearched the conference proceedings of major emergency medicine, anaesthesia, and critical care conferences from 1990 to current, and performed a grey literature search of the following: Current Controlled Trials; National Health Service – The National Research Register; ClinicalTrials.gov; NEAR website. </p> </section> <section id="CD010225-sec-0004"> <h3 class="title" id="CD010225-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials in patients undergoing emergency endotracheal intubation for critical illness, including but not limited to trauma, stroke, myocardial infarction, arrhythmia, septic shock, hypovolaemic or haemorrhagic shock, and undifferentiated shock states. We included single (bolus) dose etomidate for emergency airway intervention compared to any other rapid‐acting intravenous bolus single‐dose induction agent. </p> </section> <section id="CD010225-sec-0005"> <h3 class="title" id="CD010225-sec-0005">Data collection and analysis</h3> <p>Refinement of our initial search results by title review, and then by abstract review was carried out by three review authors. Full‐text review of potential studies was based on their adherence to our inclusion and exclusion criteria. This was decided by three independent review authors. We reported the decisions regarding inclusion and exclusion in accordance with the PRISMA statement. </p> <p>Electronic database searching yielded 1635 potential titles, and our grey literature search yielded an additional 31 potential titles. Duplicate titles were filtered leaving 1395 titles which underwent review of their titles and abstracts by three review authors. Sixty seven titles were judged to be relevant to our review, however only eight met our inclusion criteria and seven were included in our analysis. </p> </section> <section id="CD010225-sec-0006"> <h3 class="title" id="CD010225-sec-0006">Main results</h3> <p>We included eight studies in the review and seven in the meta‐analysis. Of those seven studies, only two were judged to be at low risk of bias. Overall, no strong evidence exists that etomidate increases mortality in critically ill patients when compared to other bolus dose induction agents (odds ratio (OR) 1.17; 95% confidence interval (CI) 0.86 to 1.60, 6 studies, 772 participants, moderate quality evidence). Due to a large number of participants lost to follow‐up, we performed a post hoc sensitivity analysis. This gave a similar result (OR 1.15; 95% CI 0.86 to 1.53). There was evidence that the use of etomidate in critically ill patients was associated with a positive adrenocorticotropic hormone (ACTH) stimulation test, and this difference was more pronounced at between 4 to 6 hours (OR 19.98; 95% CI 3.95 to 101.11) than after 12 hours (OR 2.37; 95% CI 1.61 to 3.47) post‐dosing. Etomidate's use in critically ill patients was associated with a small increase in SOFA score, indicating a higher risk of multisystem organ failure (mean difference (MD) 0.70; 95% CI 0.01 to 1.39, 2 studies, 591 participants, high quality evidence), but this difference was not clinically meaningful. Etomidate use did not have an effect on ICU LOS (MD 1.70 days; 95% CI ‐2.00 to 5.40, 4 studies, 621 participants, moderate quality evidence), hospital LOS (MD 2.41 days; 95% CI ‐7.08 to 11.91, 3 studies, 152 participants, moderate quality evidence), duration of mechanical ventilation (MD 2.14 days; 95% CI ‐1.67 to 5.95, 3 studies, 621 participants, moderate quality evidence), or duration of vasopressor use (MD 1.00 day; 95% CI ‐0.53 to 2.53, 1 study, 469 participants). </p> </section> <section id="CD010225-sec-0007"> <h3 class="title" id="CD010225-sec-0007">Authors' conclusions</h3> <p>Although we have not found conclusive evidence that etomidate increases mortality or healthcare resource utilization in critically ill patients, it does seem to increase the risk of adrenal gland dysfunction and multi‐organ system dysfunction by a small amount. The clinical significance of this finding is unknown. This evidence is judged to be of moderate quality, owing mainly to significant attrition bias in some of the smaller studies, and new research may influence the outcomes of our review. The applicability of these data may be limited by the fact that 42% of the patients in our review were intubated for "being comatose", a population less likely to benefit from the haemodynamic stability inherent in etomidate use, and less at risk from its potential negative downstream effects of adrenal suppression. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010225-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010225-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010225-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010225-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010225-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010225-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010225-abs-0004" lang="en"> <h3>Etomidate for sedating critically ill people during emergency endotracheal intubation</h3> <p><b>Review question</b> </p> <p>Does a single dose of etomidate increase mortality or complications in people who are critically ill and undergoing emergency endotracheal intubation? </p> <p><b>Background</b> </p> <p>People who are critically ill often need help breathing. One way to do this is called endotracheal intubation. This involves placing a tube into the windpipe (trachea) and having a ventilator (breathing machine) help the patient breathe. </p> <p>People are often given sedative agents during endotracheal intubation to make them unaware of the procedure. Many sedative agents cause a potentially harmful drop in blood pressure. </p> <p>Etomidate is commonly used to sedate patients before endotracheal intubation because it has minimal effects on blood pressure. However, when someone is given etomidate their adrenal glands do not function as well. This may be harmful to them. </p> <p><b>Study characteristics</b> </p> <p>We looked at the evidence up to February 2013 and found 1666 studies. We included eight studies in our review and seven studies (involving 772 patients) in our meta‐analysis. The studies involved people who were in an unstable condition and critically ill. They were given one dose of etomidate or another sedative agent for endotracheal intubation. We reran the search in August 2014. We will deal with any studies of interest when we update the review. </p> <p><b>Results</b> </p> <p>No strong evidence exists to suggest that etomidate, when compared to other bolus dose induction agents, increases mortality in critically ill patients. We must be careful in interpreting this finding because only large studies would be able to show a difference in mortality. So far, no such study has been completed. </p> <p>Etomidate does seem to impair adrenal gland functioning. Functioning is impaired most between four and six hours after etomidate is given. </p> <p>Sequential Organ Failure Assessment (SOFA) scores are used to find out how badly someone’s organs are failing. Using etomidate results in worse SOFA scores but this difference is small and not clinically meaningful. </p> <p>The effects of impaired adrenal gland functioning and higher SOFA scores on people’s health is unknown. Using etomidate does not seem to increase the length of time someone is in hospital (including an intensive care unit), the length of time a person is connected to a mechanical ventilator (a machine to assist with breathing), or the use of vasopressors (medicines to increase blood pressure). </p> <p><b>Quality of the evidence</b> </p> <p>Most of the evidence was moderate quality. This is mainly because some small studies we looked at did not check up on people adequately after they were intubated. </p> <p>Most people that were involved in one study were intubated because they were in a coma. These people comprise 42% of those involved in the studies we looked at. People in a coma are unlike other critically ill people because they may not benefit to the same extent from having stable blood pressure during endotracheal intubation, which etomidate provides, nor are they at high risk from impaired adrenal gland function compared to other critically ill patients, for example those with severe infection. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010225-sec-0093" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010225-sec-0093"></div> <h3 class="title" id="CD010225-sec-0094">Implications for practice</h3> <section id="CD010225-sec-0094"> <p>Based on the currently available evidence, the use of etomidate in critically ill patients does not seem to increase mortality, organ system dysfunction, or healthcare resource utilization. This observation must be interpreted with caution owing to the moderate quality of evidence, the patient population described above, and the fact that no randomized trial to date has been adequately powered to detect a mortality difference. As in non‐critically ill patients, it appears that etomidate's use does negatively affect adrenal gland function but it is unclear whether or not this adrenal gland dysfunction influences patient outcomes in the first four to six hours (more so than after 12 hours). Again, this must be interpreted with caution, acknowledging the moderate quality of evidence. The use of etomidate is associated with an increase in SOFA score indicating an increased risk of organ system dysfunction. This increase in SOFA score is not clinically meaningful. With respect to healthcare resource utilization, no strong evidence exists to suggest that etomidate increases ICU length of stay, hospital length of stay, or duration of mechanical ventilation. </p> </section> <h3 class="title" id="CD010225-sec-0095">Implications for research</h3> <section id="CD010225-sec-0095"> <p>Additional randomized trials of high quality are still required to confirm the safety of etomidate's use in critically ill patients. Due to the moderate quality of the existing evidence, new research may influence the outcomes of our review upon updating the review. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010225-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010225-sec-0029"></div> <div class="table" id="CD010225-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Etomidate versus all other induction agents for endotracheal intubation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Etomidate versus all other induction agents for endotracheal intubation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with endotracheal intubation in critically ill patients<br/> <b>Settings:</b> <br/> <b>Intervention:</b> etomidate versus all other induction agents </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Etomidate versus all other induction agents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.17</b> <br/> (0.86 to 1.6) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>772<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>296 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>330 per 1000</b><br/> (265 to 402) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>241 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>271 per 1000</b><br/> (214 to 337) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>ACTH stimulation test</b> <br/> ACTH stimulation test is considered positive if the change in serum cortisol level was less than 9 μg/dL (248 nmol/L) after the administration of 250 μg of cosyntropin<br/> Follow‐up: 24 hours </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 2.37</b> <br/> (1.61 to 3.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>519<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>228 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>411 per 1000</b><br/> (322 to 506) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>322 per 1000</b><br/> (244 to 410) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Random serum cortisol levels (μg/dL) after receiving intervention</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean random serum cortisol levels (μg/dl) after receiving intervention in the control groups was<br/> <b>21 to 28 µg/dL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean random serum cortisol levels (μg/dl) after receiving intervention in the intervention groups was<br/> <b>4.96 lower</b><br/> (8.06 to 1.86 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Organ system dysfunction</b><br/> Sequential Organ Failure Assessment (SOFA) Score. Scale from: 1 to 24 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean organ system dysfunction in the control groups was<br/> <b>9.6</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean organ system dysfunction in the intervention groups was<br/> <b>0.7 higher</b><br/> (0.01 to 1.39 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>469<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>ICU length of stay (days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ICU length of stay (days) in the control groups was<br/> <b>3 to 22 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ICU length of stay (days) in the intervention groups was<br/> <b>1.7 higher</b><br/> (2 lower to 5.4 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>621<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Hospital length of stay (days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean hospital length of stay (days) in the control groups was<br/> <b>6.4 to 10 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean hospital length of stay (days) in the intervention groups was<br/> <b>2.41 higher</b><br/> (7.08 lower to 11.91 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of mechanical ventilation (days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of mechanical ventilation (days) in the control groups was<br/> <b>1.5 to 13 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of mechanical ventilation (days) in the intervention groups was<br/> <b>2.14 higher</b><br/> (1.67 lower to 5.95 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>621<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> A significant number of patients were lost to follow‐up </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010225-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010225-sec-0030"></div> <p>More than 60% of all emergency airway interventions in the United States (US) use etomidate as the bolus induction agent (<a href="./references#CD010225-bbs2-0044" title="SivilottiMLA , FilbinMR , MurrayHE , SlasorP , WallsRM , NEAR Investigators. Does the sedative agent facilitate emergency rapid sequence intubation?. Academic Emergency Medicine2003;10(6):612‐20. [MEDLINE: 12782521] ">Sivilotti 2003</a>) owing to its favourable haemodynamic properties and ease of dosing. Data from the National Emergency Airway Registry (NEAR) show that etomidate is the most commonly used induction agent for emergency airway intervention (<a href="./references#CD010225-bbs2-0044" title="SivilottiMLA , FilbinMR , MurrayHE , SlasorP , WallsRM , NEAR Investigators. Does the sedative agent facilitate emergency rapid sequence intubation?. Academic Emergency Medicine2003;10(6):612‐20. [MEDLINE: 12782521] ">Sivilotti 2003</a>). The NEAR registry currently collects data on emergency department airway interventions from 25 hospitals in five countries. At the time of Sivilotti's publication in 2003, the database included 20 hospitals in the US, one in Canada, and one in Asia. Etomidate was used in 62% of all rapid sequence intubations (RSI) (1468 of 2380 patients) (<a href="./references#CD010225-bbs2-0044" title="SivilottiMLA , FilbinMR , MurrayHE , SlasorP , WallsRM , NEAR Investigators. Does the sedative agent facilitate emergency rapid sequence intubation?. Academic Emergency Medicine2003;10(6):612‐20. [MEDLINE: 12782521] ">Sivilotti 2003</a>). Benzodiazepines were used 18% of the time and were the next most common agents used. In the NEAR database, 63% of emergency physicians and 26% of anaesthesiologists used etomidate (<a href="./references#CD010225-bbs2-0044" title="SivilottiMLA , FilbinMR , MurrayHE , SlasorP , WallsRM , NEAR Investigators. Does the sedative agent facilitate emergency rapid sequence intubation?. Academic Emergency Medicine2003;10(6):612‐20. [MEDLINE: 12782521] ">Sivilotti 2003</a>). In the Corticosteroid Therapy of Septic Shock (CORTICUS) trial examining steroid use in septic intensive care unit (ICU) patients, 19% of these critically ill patients received etomidate (<a href="./references#CD010225-bbs2-0015" title="CuthbertsonBH , SprungCL , AnnaneD , ChevretS , GarfieldM , GoodmanS , et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Medicine2009;35(11):1868‐76. [PUBMED: 19652948] ">Cuthbertson 2009</a>). </p> <p>Etomidate suppresses the normal cortisol production of the adrenal glands through inhibition of 11‐beta‐hydroxylase. In one trial, 94% of patients receiving etomidate failed to respond to a corticotropin stimulation test (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>), but whether this suppression leads to clinically relevant outcomes is uncertain. Specifically, it is unknown if a single dose of etomidate affects the mortality of critically ill patients. Given its widespread popularity, there is potential for harm if mortality is increased through its use. Should there not be a negative effect on mortality, then many clinicians can be reassured that this medication is safe for use in the sickest patients. Either outcome of this review would be practice changing for the large number of physicians caring for critically ill patients. </p> <section id="CD010225-sec-0031"> <h3 class="title" id="CD010225-sec-0031">Description of the condition</h3> <p>Many critically ill patients require airway control, where an endotracheal tube is placed within the trachea. This procedure is painful and difficult to tolerate when awake, so most clinicians sedate patients for the procedure. Indications for airway control in critical illness are numerous but broadly include airway protection when airway patency is threatened by distorted anatomy or the patient's level of consciousness. This therapy is also used to support respiratory failure and to allow mechanical ventilation in patients with haemodynamic instability, including patients with septic shock and other critical illnesses. </p> <p>Patients requiring this therapy typically have abnormal vital signs including hypotension, tachycardia, hypoxia, or an altered level of consciousness. Insults to the patient's central nervous system (CNS) and other vital organs may be exacerbated if the induction agents worsen hypotension. Rapidly acting induction agents decrease critically ill patients' blood pressure further through vasodilatory effects or direct myocardial suppression, or both. </p> </section> <section id="CD010225-sec-0032"> <h3 class="title" id="CD010225-sec-0032">Description of the intervention</h3> <p>When faced with the decision to obtain airway control in critically ill patients, clinicians must weigh the benefits and potential harms of a multitude of pharmacological agents. They must then apply this decision to a complex and dynamic physiological state in patients sensitive to further physiological insults. Several classes of agents are used to sedate critically ill patients, each with their own benefits and weaknesses. </p> <p>Etomidate is a short‐acting intravenous (IV) medication used for anaesthesia induction and sedation. Single‐dose etomidate is commonly used to facilitate endotracheal intubation in critically ill patients because etomidate is less likely to cause a harmful drop in blood pressure than other induction agents, after an induction dose of 0.3 mg/kg IV. After this dose, there are minimal changes in heart rate, stroke volume, or cardiac output; and mean arterial blood pressure may decrease up to 15% because of decreases in systemic vascular resistance. Etomidate (1‐(1‐phenylethyl)‐1H‐imidazole‐5‐carboxylic acid ethyl ester) is a carboxylated imidazole derivative used for the induction of general anaesthesia. Following a standard dose (0.3 mg/kg), hypnosis occurs in less than one minute and is maintained for 4 to 10 minutes by producing gamma‐aminobutyric acid (GABA)‐like effects on the CNS. </p> <p>Benzodiazepines (midazolam, lorazepam, diazepam, etc.) induce CNS depression through GABA effects. Midazolam is a commonly used rapid‐acting benzodiazepine for RSI. Midazolam, when administered as an IV bolus (0.05 to 0.15 mg/kg) for induction of anaesthesia has an onset of action of one to two minutes. Duration of action after an induction dose of 0.15 mg/kg IV to young healthy volunteers was 17 minutes to awakening. The clinical effects of midazolam can be prolonged in elderly patients or patients with impaired renal or hepatic function. </p> <p>Propofol (2,6‐diisopropylphenol) is presumed to exert its sedative‐hypnotic effects through a GABA receptor interaction. At a standard dose of 1.5 to 2.5 mg/kg IV, anaesthesia is induced in less than one minute (10 to 50 seconds) and is maintained for five minutes. Propofol produces decreases in systemic blood pressure and has a negative inotropic effect. Bradycardia and asystole have been observed after induction of anaesthesia with propofol, potentially owing to a decrease in sympathetic nervous system activity that results in a predominance of parasympathetic activity. </p> <p>Opiate derivatives (morphine, fentanyl, remifentanil, etc.) in large doses have been used as the sole anaesthetic in critically ill patients. Morphine and hydromorphone can cause histamine release, which causes hypotension owing to peripheral vasodilation. Fentanyl and remifentanil do not cause release of histamine. Dose, metabolism, elimination, and side effects vary depending on the opioid administered. Morphine, hydromorphone, and remifentanil may produce mild decreases in systemic blood pressure and heart rate. Fentanyl may produce bradycardia. </p> <p>Ketamine is another induction agent with favourable haemodynamic and kinetic profiles. At IV bolus doses of 1 to 2 mg/kg for induction, dissociation occurs within 30 to 60 seconds with a duration of action of 10 to 20 minutes. Ketamine produces cardiovascular effects that resemble sympathetic nervous system stimulation. The mechanisms for these ketamine‐induced cardiovascular effects are complex. Direct stimulation of the CNS leading to increased sympathetic nervous system outflow seems to the most important mechanism for cardiovascular stimulation (<a href="./references#CD010225-bbs2-0048" title="WongDHW , JenkinsLC . Experimental study of mechanism of action of ketamine on central nervous system. Canadian Anaesthetists Society Journal1974;21(1):57‐67. ">Wong 1974</a>). This may result in an increase in systemic and pulmonary arterial blood pressure, heart rate, cardiac output, cardiac workload, and therefore myocardial oxygen demand. Ketamine also has a direct negative cardiac inotropic effect. This effect is usually overshadowed by central sympathetic stimulation but occasionally critically ill patients respond to ketamine with decreases in systemic blood pressure and cardiac output, which may reflect depletion of endogenous catecholamine stores and exhaustion of sympathetic nervous system compensatory mechanisms. It is not known to inhibit the adrenal axis (<a href="./references#CD010225-bbs2-0046" title="StoeltingR , HillerS . Pharmacology &amp; Physiology in Anesthetic Practice. Fourth. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. ">Stoelting 2006</a>).  </p> </section> <section id="CD010225-sec-0033"> <h3 class="title" id="CD010225-sec-0033">How the intervention might work</h3> <p>The use of etomidate infusions in the ICU setting has been largely abandoned secondary to adrenal suppression and increased mortality. This is thought to be mediated by etomidate's transient, reversible suppression of 11‐beta‐hydroxylase, an enzyme responsible for the production of active steroids from the adrenal glands (<a href="./references#CD010225-bbs2-0034" title="deJongFH , MalliosC , JansenC , ScheckPA , LambertsSW . Etomidate suppresses adrenocortical function by inhibition of 11 beta‐hydroxylation. Journal of Clinical Endocrinology and Metabolism2084;59:1143‐7. [MEDLINE: 6092411] ">de Jong 1984</a>). There is a growing body of literature supporting the hypothesis that even single‐dose etomidate causes adrenal suppression (<a href="./references#CD010225-bbs2-0034" title="deJongFH , MalliosC , JansenC , ScheckPA , LambertsSW . Etomidate suppresses adrenocortical function by inhibition of 11 beta‐hydroxylation. Journal of Clinical Endocrinology and Metabolism2084;59:1143‐7. [MEDLINE: 6092411] ">de Jong 1984</a>; <a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0025" title="ZedPJ , Abu‐LabanRB , HarrisonDW . Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study. Academic Emergency Medicine2006;13(4):378‐83. [PUBMED: 16531603] ">Zed 2006</a>). The association of adrenal dysfunction in septic shock patients, and the possible survival benefit from exogenous steroids, has been debated and investigated in the critical care literature (<a href="./references#CD010225-bbs2-0030" title="AnnaneD , SébilleV , CharpentierC , BollaertPE , FrançoisB , KorachJM , et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA2002;288:862‐71. [MEDLINE: 12186604] ">Annane 2002</a>; <a href="./references#CD010225-bbs2-0031" title="AnnaneD , BellissantE , BollaertPE , BriegelJ , KehD , KupferY . Corticosteroids for severe sepsis and septic shock: a systematic review and meta‐analysis. BMJ2004;480:329‐480. [MEDLINE: 15289273] ">Annane 2004</a>; <a href="./references#CD010225-bbs2-0033" title="CroninL , CookDJ , CarletJ , HeylandDK , KingD , LansangMA , et al. Corticosteroid treatment for sepsis: a critical appraisal and meta‐analysis of the literature. Critical Care Medicine1995;23:1430‐9. [MEDLINE: 7634816] ">Cronin 1995</a>; <a href="./references#CD010225-bbs2-0045" title="SprungCL , AnnaneD , KehD , MorenoR , SingerM , FreivogelK , et al. Hydrocortisone therapy for patients with septic shock. New England Journal of Medicine2008;8:111‐24. [MEDLINE: 18184957] ">Sprung 2008</a>). </p> <p>Whether the adrenal dysfunction has a causal role in mortality, or is simply another indicator of organ dysfunction, remains unclear.  </p> </section> <section id="CD010225-sec-0034"> <h3 class="title" id="CD010225-sec-0034">Why it is important to do this review</h3> <p>Debate remains regarding the clinical effects of single dose etomidate in critically ill patients. Systematic reviews on the subject have led to conflicting results. </p> <p>Hohl et al pooled data from seven studies examining the effects of etomidate in critically ill patients. None of the individual studies were powered to detect a mortality difference, and a pooled odds ratio (OR) estimate of mortality showed no statistical difference (<a href="./references#CD010225-bbs2-0039" title="HohlCM , Kelly‐SmithCH , YeungTC , SweetDD , Doyle‐WatersMM , SchulzerM . The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: a systematic review. Annals of Emergency Medicine2010;56:105‐13. [PUBMED: 20346542] ">Hohl 2010</a>). </p> <p>Albert et al published a systematic review of 19 etomidate trials (<a href="./references#CD010225-bbs2-0029" title="AlbertSG , AriyanS , RatherA . The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Medicine2011;37(6):901‐10. [PUBMED: 21373823] ">Albert 2011</a>). The authors concluded that strong evidence exists for an increased relative risk for etomidate‐induced adrenal suppression. They also stated that weak evidence exists for any association between etomidate and mortality. The authors very correctly assert that the mortality conclusions are weak based on: "a preponderance of non‐randomized trials and heterogeneity of studies". In their review, Albert et al combined clinically heterogeneous data from 15 retrospective, observational, and non‐randomized trials with four prospective randomized trials. The conclusion that etomidate use is associated with greater mortality in critically ill patients must be interpreted with caution (<a href="./references#CD010225-bbs2-0029" title="AlbertSG , AriyanS , RatherA . The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Medicine2011;37(6):901‐10. [PUBMED: 21373823] ">Albert 2011</a>). </p> <p>Chan and colleagues also published a meta‐analysis of randomized controlled trials and observational studies examining the effects of etomidate on adrenal insufficiency and all‐cause mortality in septic patients. In this meta‐analysis, they report a pooled relative risk of 1.20 (95% confidence interval (CI) 1.02 to 1.42) for mortality, and a pooled relative risk of 1.33 (95% CI 1.22 to 1.46) for the development of adrenal insufficiency (<a href="./references#CD010225-bbs2-0032" title="ChanCM , MitchellAL , ShorrAF . Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta‐analysis. Critical Care Medicine2012;40(11):2945‐53. [PUBMED: 22971586] ">Chan 2012</a>). The practice of combining observational and randomized data is methodologically questionable, and the results must be interpreted with caution. </p> <p>While it is clear that etomidate is associated with transient adrenal suppression, the literature has yet to answer whether or not this effect is clinically meaningful. It is also unclear whether the immediate haemodynamic safety benefits of etomidate outweigh its potential harm from transient adrenal suppression. </p> <p>Given the vast number of doses administered on an annual basis to critically ill patients, there exists a risk of harm if mortality is affected by etomidate‐induced adrenal suppression. Should no harm be identified, then physicians can be reassured that the use of an otherwise favourable drug is safe.  </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010225-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010225-sec-0035"></div> <p>The primary objective was to assess, in populations of critically ill patients, whether a single induction dose of etomidate for emergency airway intervention affects mortality. </p> <p>The secondary objectives were to address, in populations of critically ill patients, whether a single induction dose of etomidate for emergency airway intervention affects adrenal gland function, organ dysfunction, or health services utilization (as measured by ICU length of stay (LOS), duration of mechanical ventilation, or vasopressor requirements). </p> <p>We repeated analyses within subgroups defined by the aetiologies of critical illness, timing of adrenal gland function measurement, and the type of comparator drug used. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010225-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010225-sec-0036"></div> <section id="CD010225-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010225-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs).</p> <p>We excluded non‐randomized or quasi‐randomized trials.</p> </section> <section id="CD010225-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included adult and paediatric patients undergoing emergency endotracheal intubation (defined as endotracheal intubation for an unstable clinical condition) for critical illness, including but not limited to: trauma, stroke, myocardial infarction, arrhythmia, septic shock, hypovolaemic or haemorrhagic shock, and undifferentiated shock states.  </p> <p>We excluded elective anaesthesia induction in stable patients.</p> </section> <section id="CD010225-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included a single (bolus) dose of etomidate for emergency airway intervention compared to any other rapid‐acting IV bolus single‐dose induction agent (ketamine, midazolam, propofol, thiopental, etc.). </p> <p>We excluded etomidate infusions and etomidate use for indications other than airway intervention (for example procedural sedation). </p> </section> <section id="CD010225-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD010225-sec-0042"> <h5 class="title">Primary outcomes</h5> <p>  All‐cause mortality. Mortality data at 30 days (including sensitivity analysis of death before 24 hours, up to 7 days, and 28 days) will be reported if available. </p> </section> <section id="CD010225-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010225-list-0001"> <li> <p>Mortality at 30 days within groups of patients with adrenal gland dysfunction, as available in published reports. </p> </li> <li> <p>Adrenal gland dysfunction (at times &lt; 4 hours, between 4 to 6 hours, between 6 to 12 hours, and &gt; 12 hours from etomidate dose) as described by <a href="./references#CD010225-bbs2-0041" title="MarikPE , PastoresSM , AnnaneD , MeduriGU , SprungCL , ArltW , et al. American College of Critical Care Medicine. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Critical Care Medicine2008;36(6):1937‐49. [MEDLINE: 18496365] ">Marik 2008</a>, defined as: </p> <ol id="CD010225-list-0002"> <li> <p>random cortisol level &lt; 10 μg/dL (276 nmol/L);</p> </li> <li> <p>failed adrenocorticotropic hormone (ACTH) stimulation tests where the delta cortisol is &lt; 9 μg/dL (248 nmol/L) after a 250 μg cosyntropin administration (or body surface‐area appropriate dose in the paediatric population). </p> </li> </ol> </li> <li> <p>Organ dysfunction:</p> <ol id="CD010225-list-0003"> <li> <p>Sequential Organ Failure Assessment (SOFA) score;</p> </li> <li> <p>other validated systems for reporting organ dysfunction.</p> </li> </ol> </li> <li> <p>ICU LOS (sensitivity analysis stratified by patients who died before 24 hours, within 7 days, and within 28 days). </p> </li> <li> <p>Duration of mechanical ventilation (sensitivity analysis stratified by patients who died before 24 hours, within 7 days, and within 28 days). </p> </li> <li> <p>Vasopressor requirements (duration in days of any vasoactive medication infusion).</p> </li> </ol> </p> </section> </section> </section> <section id="CD010225-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010225-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2012, Issue 12); MEDLINE via OvidSP (1950 to 8 February 2013); CINAHL (EBSCOhost) (1982 to 8 February 2013); EMBASE via OvidSP (1980 to 8 February 2013); LILACS (BIREME) (1982 to 8 February 2013); International Pharmaceutical Abstracts (1970 to 8 February 2013); Web of Science (1980 to 8 February 2013); the Database of Abstracts of Reviews of Effects (DARE) (8 February 2013); and ISI BIOSIS Citation index<sup>SM</sup> (1969 to 8 February 2013). </p> <p>We also searched the Scopus database of dissertations and conference proceedings (1980 to 8 February 2013) and the US Food and Drug Administration (FDA) Database (1980 to 8 February 2013). </p> <p>We did not limit the selection of studies by region of publication or by language.</p> <p>We adopted the MEDLINE search strategy for searching all other databases (see <a href="./appendices#CD010225-sec-0099">Appendix 1</a> for detailed search strategies). </p> <p>We reran the search in August, 2014. We will deal with any studies of interest when we update the review. </p> </section> <section id="CD010225-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We handsearched the following medical journals from 2000 to February 2013:</p> <p> <ul id="CD010225-list-0004"> <li> <p><i>Annals of Emergency Medicine;</i> </p> </li> <li> <p><i>Academic Emergency Medicine;</i> </p> </li> <li> <p><i>Canadian Journal of Emergency Medicine;</i> </p> </li> <li> <p><i>Emergency Medicine Clinics of North America;</i> </p> </li> <li> <p><i>Journal of Emergency Medicine;</i> </p> </li> <li> <p><i>Anesthesiology;</i> </p> </li> <li> <p><i>Canadian Journal of Anesthesia;</i> </p> </li> <li> <p><i>Anesthesia and Analgesia;</i> </p> </li> <li> <p><i>British Journal of Anaesthesia;</i> </p> </li> <li> <p><i>Journal of Trauma;</i> </p> </li> <li> <p><i>Intensive Care Medicine;</i> </p> </li> <li> <p><i>Critical Care Medicine</i>; </p> </li> <li> <p><i>Chest</i>; </p> </li> <li> <p><i>American Journal of Respiratory and Critical Care Medicine</i>. </p> </li> </ul> </p> <p>We searched the conference proceedings of major emergency medicine, anaesthesia, and critical care conferences from 1990 to February 2013 to identify data published in abstract form only. </p> <p>A grey literature search included electronic searches of the following clinical trial registry websites: </p> <p> <ul id="CD010225-list-0005"> <li> <p>Current Controlled Trials;</p> </li> <li> <p>National Health Service – The National Research Register;</p> </li> <li> <p>ClinicalTrials.gov;</p> </li> <li> <p>NEAR website.</p> </li> </ul> </p> <p>We contacted authors of all ongoing trials for unreported data. We contacted drug manufacturers and asked them to provide any published or unpublished data, however these publications were not provided to us, citing that, "Clinical studies not already published are proprietary information. Regretfully, for this reason, this data cannot be provided" (<a href="./references#CD010225-bbs2-0040" title="LloydJ . Inquiry Response for Hospira US2013‐11982 [personal communication]. E‐mail to: E Bruder 10 July, 2013. ">Lloyd 2013 [pers comm]</a>). </p> <p>The bibliographies of all relevant retrieved articles identified in the search above were handsearched for any missed studies. </p> </section> </section> <section id="CD010225-sec-0047"> <h3 class="title" id="CD010225-sec-0047">Data collection and analysis</h3> <section id="CD010225-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Refinement of our initial search results by title review and then by abstract review was carried out by three review authors (EB, IB, SR). We decided the final inclusion for full‐text review by majority vote (two out of three). </p> <p>Full‐text review of potential studies was based on their adherence to our inclusion and exclusion criteria. This was decided by three independent review authors (EB, IB, SR). We resolved disagreements by open discussion and consensus agreement, with the principle review author (EB) making the final decision. If required, we contacted the authors of studies to clarify their eligibility for inclusion and whether their publication was a duplicate report of a single study. If any doubt remained, the default was inclusion for data extraction. </p> <p>We reported the decisions regarding inclusion and exclusion in accordance with the PRISMA statement (<a href="#CD010225-fig-0001">Figure 1</a>). We analysed multiple reports of a single study as a single study. </p> <div class="figure" id="CD010225-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010225-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We were not blinded to the authors or journals of publication.</p> </section> <section id="CD010225-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Three review authors (EB, IB, SR) independently extracted the data from studies using a data extraction form (see <a href="./appendices#CD010225-sec-0107">Appendix 2</a>). We (EB, IB, SR) pilot tested the data extraction form on 10 articles selected at random from our initial search strategy and applied it to studies that both met, and did not meet, our inclusion criteria. We did not modify the data extraction methodology and form after this pilot test. </p> <p>We extracted the following data, according to outcome:</p> <p> <ul id="CD010225-list-0006"> <li> <p>all‐cause mortality;</p> </li> </ul> <ul id="CD010225-list-0007"> <li> <p>Adrenal gland dysfunction:</p> <ul id="CD010225-list-0008"> <li> <p>random serum cortisol levels,</p> </li> </ul> <ul id="CD010225-list-0009"> <li> <p>positive ACTH stimulation tests;</p> </li> </ul> </li> <li> <p>Health services utilization:</p> <ul id="CD010225-list-0010"> <li> <p>hospital LOS in days (mean, standard deviation (SD), numbers (n); as well as median and interquartile range (IQR) as reported), </p> </li> <li> <p>ICU LOS in days (mean, SD, n; as well as median and IQR as reported),</p> </li> <li> <p>duration of mechanical ventilation in days (mean, SD, n; as well as median and IQR as reported), </p> </li> <li> <p>vasopressor requirements,</p> <ul id="CD010225-list-0011"> <li> <p>duration of any vasopressor requirement in days (mean, SD, n).</p> </li> </ul> </li> </ul> </li> </ul> </p> </section> <section id="CD010225-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We performed risk of bias assessments using the 'Risk of bias' tool described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010225-bbs2-0037" title="Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We assessed each trial according to the quality domains of random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and any other potential threats to validity. We judged each criterion regarding its risk of bias and recorded an assessment of the magnitude and direction of each source of bias. Data points for the risk of bias assessment are part of our data extraction form, attached as <a href="./appendices#CD010225-sec-0107">Appendix 2</a>. </p> <p>We considered a trial to have a low risk of bias if all domains were assessed as adequate. We considered a trial to have a high risk of bias if one or more domain was assessed as inadequate or unclear. </p> <p>We report the 'Risk of bias' table (<a href="#CD010225-fig-0002">Figure 2</a>) as part of the table 'Characteristics of included studies' and present a 'Risk of bias summary' figure (<a href="#CD010225-fig-0003">Figure 3</a>), which details all of the judgements made for all included studies in the review. </p> <div class="figure" id="CD010225-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010225-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010225-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010225-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>We assessed the risk of bias for each outcome independently. Studies were not weighted by risk of bias for our analysis. </p> </section> <section id="CD010225-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We reported the odds ratio (OR) for dichotomous data (mortality, ACTH stimulation tests). We reported the mean difference (MD) and SD for continuous data with the same unit of measure, and the standardized mean difference (SMD) for continuous data that were reported using different units of measure (hospital and ICU LOS, duration of mechanical ventilation, duration of vasopressor requirements, serum cortisol levels). Serum cortisol levels reported in nmol/L were converted to μg/dL, where possible, using the 'SIU Conversion Calculator' embedded within the Micromedex 2.0 system by Truven Health Analytics Inc (<a href="./references#CD010225-bbs2-0047" title="Truven Health Ac. Micromedex 2.0 SIU Conversion Calculator. http://www.micromedexsolutions.com/micromedex2/librarian/ND_T/evidencexpert/ND_PR/evidencexpert/CS/02664B/ND_AppProduct/evidencexpert/DUPLICATIONSHIELDSYNC/61BF2F/ND_PG/evidencexpert/ND_B/evidencexpert/ND_P/evidencexpert/PFActionId/evidencexpert.Calculators#Accessed July, 2013. ">Truven 2013</a>). </p> <p>Variables with non‐normal distributions, reported as medians with IQRs, were assumed to be normally distributed for the purposes of this analysis. The median was assumed to be an acceptable estimation of the mean, and the IQR was considered to be 1.35 times the SD. This process is described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010225-bbs2-0037" title="Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) and has been used by other review authors in the past (<a href="./references#CD010225-bbs2-0049" title="ZachariasM , MugawarM , HerbisonGP , WalkerRJ , HovhannisyanK , SivalingamP , ConlonNP . Interventions for protecting renal function in the perioperative period. Cochrane Database of Systematic Reviews2013, Issue 9. [DOI: 10.1002/14651858.CD003590.pub4] ">Zacharias 2013</a>). </p> </section> <section id="CD010225-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the patient.</p> <p>In studies with multiple treatment arms, only interventions relevant to our review were included for analysis, and a description of these studies is included in the '<a href="./references#CD010225-sec-0113" title="">Characteristics of included studies</a>' table. We combined all control groups (for example propofol, ketamine, and benzodiazepines) for comparison with the intervention (etomidate). We analysed each pair‐wise comparison separately as subgroup analyses for mortality. For dichotomous outcomes, such as mortality, we divided the number of events and the total number of patients in proportions similar to the proportions of the total number of participants per experimental group. </p> <p>The nature of the intervention precluded case cross‐over trial designs. Therefore, we did not encounter any of these study designs. Cluster‐randomized trials were included in our analysis if they reported the outcome data ignoring the cluster design for the total number of individuals. </p> </section> <section id="CD010225-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>Whenever possible, we contacted the authors of studies and asked for primary data (<a href="./references#CD010225-bbs2-0002" title="CinarO , PiratA , ZeynelogluP , BayraktarN , ArslanG . Hemodynamic and metabolic responses to ketamine and etomidate sedations during endotracheal intubation in critically ill patients. Critical Care Medicine. Conference: 40th Critical Care Congress of the Society of Critical Care Medicine San Diego, CA United States. San Diego, CA United States, 2010; Vol. 38 (12 Suppl). ">Cinar 2010</a>; <a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0006" title="KoksalG . The effect of single dose of etomidate used during emergency intubation on hemodynamics and adrenal cortex. Unpublished manuscript N/A. ">Koksal 2013</a>). </p> <p>Where this was not possible, we performed an intention‐to‐treat (ITT) analysis on mortality data where we assumed that all missing data represented patient deaths in both the intervention and control groups. </p> </section> <section id="CD010225-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We only pooled data meta‐analytically for clinically homogenous data reporting the same outcome measures. For all pooled data, we used the Chi<sup>2</sup> statistic, degrees of freedom, and the I<sup>2</sup> statistic to assess the degree of statistical heterogeneity across the studies. If the I<sup>2</sup> was &lt; 40%, we reported the results of pooled data using meta‐analytic techniques. If the I<sup>2</sup> was &gt; 40%, we used sensitivity analysis to explore potential causes for the heterogeneity. </p> </section> <section id="CD010225-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>We did not employ a funnel plot of included studies to ensure that reporting bias did not significantly affect our findings as fewer than 10 trials were included (<a href="./references#CD010225-bbs2-0035" title="EggerM , SmithGD , PhillipsAN . Meta‐analysis: principles and procedures. BMJ1997;315(7121):1533‐7. [MEDLINE: 9432252] ">Egger 1997</a>) in this review. </p> </section> <section id="CD010225-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We conducted a meta‐analysis, using a random‐effects model, for studies with similar design and interventions. </p> <p>We report ORs with 95% confidence intervals (CIs) for dichotomous variables such as mortality, and MDs with 95% CIs for continuous variables. When different scales or units were used to report continuous data, we calculated and reported the SMDs. </p> </section> <section id="CD010225-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed subgroup analysis on the following:</p> <p> <ul id="CD010225-list-0012"> <li> <p>comparator drug;</p> </li> <li> <p>different aetiologies of critical illness (i.e. septic, cardiogenic, trauma, undifferentiated).</p> </li> </ul> </p> <p>We had planned to perform a subgroup analysis on paediatric patients, but no reports of paediatric patients were identified. </p> </section> <section id="CD010225-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses on the following data:</p> <p> <ul id="CD010225-list-0013"> <li> <p>mortality timing, less than 24 hours versus 7 days, 28 days, and all;</p> </li> <li> <p>ICU LOS stratified by timing of mortality;</p> </li> <li> <p>duration of mechanical ventilation stratified by timing of mortality;</p> </li> <li> <p>sensitivity analysis where studies assessed as being at high risk of bias were excluded.</p> </li> </ul> </p> <p>We were unable to conduct these sensitivity analyses due to unavailable data.</p> <p>We conducted sensitivity analysis to assess the impact of excluding poor quality studies, assessed as being at high risk of bias. Only two studies were judged to be at low risk of bias (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>). </p> <section id="CD010225-sec-0059"> <h5 class="title">Summary of findings tables</h5> <p>We used the principles of the GRADE system (<a href="./references#CD010225-bbs2-0036" title='GuyattGH , OxmanAD , KunzR , VistGE , Flack‐YtterY , Schunemann HJ. GRADE Working Group. What is "quality of evidence" and why is it important to clinicians. BMJ2008;336:995‐8. [MEDLINE: 18456631] '>Guyatt 2008</a>) to assess the quality of the body of evidence associated with specific outcomes (mortality, adrenal gland dysfunction, organ dysfunction, ICU LOS) in our review and constructed a summary of findings (SoF) table using the GRADE software. The GRADE approach appraises the quality of a body of evidence based on the extent to which we can be confident that an estimate of effect or association reflects the item being assessed. The quality of a body of evidence considers within study risk of bias (methodological quality), the directness of the evidence, heterogeneity of the data, precision of effect estimates, and risk of publication bias. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010225-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010225-sec-0060"></div> <section id="CD010225-sec-0061"> <h3 class="title">Description of studies</h3> <p>See the '<a href="./references#CD010225-sec-0113" title="">Characteristics of included studies</a>' and '<a href="./references#CD010225-sec-0114" title="">Characteristics of excluded studies</a>' tables below. </p> <section id="CD010225-sec-0062"> <h4 class="title">Results of the search</h4> <p>Electronic database searching yielded 1635 potential titles, and our grey literature search yielded an additional 31 potential tiles. Duplicate titles were filtered leaving 1395 titles which underwent review of their titles and abstracts by three review authors (EB, IB, SR). We judged 68 titles to be relevant to our review, however only eight met our inclusion criteria. One title (<a href="./references#CD010225-bbs2-0002" title="CinarO , PiratA , ZeynelogluP , BayraktarN , ArslanG . Hemodynamic and metabolic responses to ketamine and etomidate sedations during endotracheal intubation in critically ill patients. Critical Care Medicine. Conference: 40th Critical Care Congress of the Society of Critical Care Medicine San Diego, CA United States. San Diego, CA United States, 2010; Vol. 38 (12 Suppl). ">Cinar 2010</a>) met our inclusion criteria but could not be included in our meta‐analysis because it was a poster at a research meeting that did not present its numerical data. This paper presented results like "Groups’ mean serum cortisol and 11b‐deoxycortisol concentrations were similar before and five minutes after intubation (P &lt; 0.05). The groups were not significantly different with regards to intubation conditions, length of ICU stay, duration of mechanical ventilation, and mortality (P &lt; 0.05)" (<a href="./references#CD010225-bbs2-0002" title="CinarO , PiratA , ZeynelogluP , BayraktarN , ArslanG . Hemodynamic and metabolic responses to ketamine and etomidate sedations during endotracheal intubation in critically ill patients. Critical Care Medicine. Conference: 40th Critical Care Congress of the Society of Critical Care Medicine San Diego, CA United States. San Diego, CA United States, 2010; Vol. 38 (12 Suppl). ">Cinar 2010</a>). Multiple attempts were made to contact both the primary and supervising authors, but no reply was received. As a result we included seven studies in our meta‐analysis (<a href="#CD010225-fig-0001">Figure 1</a>). </p> <p>We reran our search on 22 August 2014 and identified an additional three studies of interest (<a href="./references#CD010225-bbs2-0026" title="DriverB , MooreJ , ReardonR , SteinbergL , AntolickA , UsherS , MinerJ . Ketamine versus etomidate for ED rapid sequence intubation. Academic Emergency Medicine2014;21: 5 Suppl 1:S117. ">Driver 2014</a>; <a href="./references#CD010225-bbs2-0027" title="FreundY , JabreP , MouradJ , LapostolleF , ReuterPG , WoimantM , et al. Relative adrenal insufficiency in critically ill patient after rapid sequence intubation: KETASED ancillary study. Journal of Critical Care2014;29(3):386‐9. ">Freund 2014</a>; <a href="./references#CD010225-bbs2-0028" title="PuntCD , DormansTPJ , OosterhuisWP , BoerW , DepoorterB , van derLindenCJ , et al. Etomidate and S‐ketamine for the intubation of patients on the intensive care unit: A prospective, open‐label study. Netherlands Journal of Critical Care2014;18(2):4‐7. ">Punt 2014</a>). We will deal with these studies of interest when we update the review. </p> </section> <section id="CD010225-sec-0063"> <h4 class="title">Included studies</h4> <p>We included eight studies in our review and seven studies in our meta‐analysis. All seven were RCTs of critically ill patients requiring emergency airway intervention, with a combined census of 772 patients. The studies were conducted in North American (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>) or European (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>; <a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0006" title="KoksalG . The effect of single dose of etomidate used during emergency intubation on hemodynamics and adrenal cortex. Unpublished manuscript N/A. ">Koksal 2013</a>) tertiary care centres, or in pre‐hospital settings in the United States (<a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>). All studies randomized patients to receive etomidate or other single‐dose induction agents including thiopentone (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>), fentanyl and midazolam (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>), ketamine (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>), or midazolam alone (<a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>; <a href="./references#CD010225-bbs2-0006" title="KoksalG . The effect of single dose of etomidate used during emergency intubation on hemodynamics and adrenal cortex. Unpublished manuscript N/A. ">Koksal 2013</a>; <a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>). </p> <p>There were differences in the overall mortality rates reported within the studies, which may suggest clinical heterogeneity. Most studies reported an overall mortality rate of 23% to 38% (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>; <a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>), however two studies reported overall mortality rates of 3% (<a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>) and 7% (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>). </p> </section> <section id="CD010225-sec-0064"> <h4 class="title">Excluded studies</h4> <p>We excluded 17 studies. The majority of these studies were excluded because of their observational design or they were retrospective reviews of charts or databases. Please refer to '<a href="./references#CD010225-sec-0114" title="">Characteristics of excluded studies</a>'. Three studies warranted specific discussion (<a href="./references#CD010225-bbs2-0009" title="AsehnouneK , MahePJ , SeguinP , JaberS , JungB , GuittonC , et al. Etomidate increases susceptibility to pneumonia in trauma patients. Intensive Care Medicine2012;38(10):1673‐82. [PUBMED: 22777514] ">Asehnoune 2012</a>; <a href="./references#CD010225-bbs2-0013" title="CherfanAJ , TamimHM , AlJumahA , RishuAH , Al‐AbdulkareemA , Al KnawyBA , et al. Etomidate and mortality in cirrhotic patients with septic shock. BMC Clinical Pharmacology2011;11:22. [PUBMED: 22208901] ">Cherfan 2011</a>; <a href="./references#CD010225-bbs2-0015" title="CuthbertsonBH , SprungCL , AnnaneD , ChevretS , GarfieldM , GoodmanS , et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Medicine2009;35(11):1868‐76. [PUBMED: 19652948] ">Cuthbertson 2009</a>). </p> <p>Asehnoune reported a substudy of the HYPOLYTE trial, which intended to report the impact of etomidate on the rate of hospital acquired pneumonia in trauma patients intubated for more than 48 hours. They also performed ACTH stimulation tests. While the use of etomidate was prospectively collected, the participants in this trial were randomized, in a double blind, placebo controlled manner, to receive either hydrocortisone or placebo. These patients were not randomized to receive etomidate or other induction agents (<a href="./references#CD010225-bbs2-0009" title="AsehnouneK , MahePJ , SeguinP , JaberS , JungB , GuittonC , et al. Etomidate increases susceptibility to pneumonia in trauma patients. Intensive Care Medicine2012;38(10):1673‐82. [PUBMED: 22777514] ">Asehnoune 2012</a>). </p> <p>Cherfan evaluated the effect of low‐dose steroids on septic patients intubated with etomidate. This was a nested cohort study within a RCT, which evaluated the use of low‐dose hydrocortisone in septic cirrhotic patients. Mortality was compared between groups who did, and did not, receive etomidate (<a href="./references#CD010225-bbs2-0013" title="CherfanAJ , TamimHM , AlJumahA , RishuAH , Al‐AbdulkareemA , Al KnawyBA , et al. Etomidate and mortality in cirrhotic patients with septic shock. BMC Clinical Pharmacology2011;11:22. [PUBMED: 22208901] ">Cherfan 2011</a>). </p> <p>Cuthbertson's study received a lot of attention when published. It concluded that etomidate use was associated with a statistically significant increase in mortality (61.0% versus 44.6%) and the authors cautioned against using etomidate. This study was an a priori substudy of the CORTICUS trial, a multi‐centre, double blind, placebo controlled RCT comparing patients who received either hydrocortisone or placebo. Cuthbertson's report compared mortality in patients who received etomidate within 72 hours of enrolment to those who did not. It may stand to reason that the higher mortality rate seen in the etomidate group was due to their more severe underlying illness and was not an effect of the drug. Using multivariate analysis, the authors controlled for the severity of illness and still showed an increase in mortality (42.7% versus 30.5%) in the patients who received etomidate. This study was excluded from our analysis because individual patients were randomized to receive either placebo or hydrocortisone, and the data relating to the exposure to etomidate was observational (<a href="./references#CD010225-bbs2-0015" title="CuthbertsonBH , SprungCL , AnnaneD , ChevretS , GarfieldM , GoodmanS , et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Medicine2009;35(11):1868‐76. [PUBMED: 19652948] ">Cuthbertson 2009</a>). </p> <section id="CD010225-sec-0065"> <h5 class="title">Studies awaiting classification</h5> <p>Three studies (<a href="./references#CD010225-bbs2-0026" title="DriverB , MooreJ , ReardonR , SteinbergL , AntolickA , UsherS , MinerJ . Ketamine versus etomidate for ED rapid sequence intubation. Academic Emergency Medicine2014;21: 5 Suppl 1:S117. ">Driver 2014</a>; <a href="./references#CD010225-bbs2-0027" title="FreundY , JabreP , MouradJ , LapostolleF , ReuterPG , WoimantM , et al. Relative adrenal insufficiency in critically ill patient after rapid sequence intubation: KETASED ancillary study. Journal of Critical Care2014;29(3):386‐9. ">Freund 2014</a>; <a href="./references#CD010225-bbs2-0028" title="PuntCD , DormansTPJ , OosterhuisWP , BoerW , DepoorterB , van derLindenCJ , et al. Etomidate and S‐ketamine for the intubation of patients on the intensive care unit: A prospective, open‐label study. Netherlands Journal of Critical Care2014;18(2):4‐7. ">Punt 2014</a>) are awaiting classification (see '<a href="./references#CD010225-sec-0115" title="">Characteristics of studies awaiting classification</a>'). We will deal with these studies of interest when we update the review. </p> </section> </section> </section> <section id="CD010225-sec-0066"> <h3 class="title">Risk of bias in included studies</h3> <p>Please refer to our '<a href="./references#CD010225-sec-0113" title="">Characteristics of included studies</a>', risk of bias graph (<a href="#CD010225-fig-0002">Figure 2</a>), and risk of bias summary (<a href="#CD010225-fig-0003">Figure 3</a>) for our judgements regarding each study's risk of bias. Overall, only two studies (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>) were judged to be at low risk of bias. </p> <section id="CD010225-sec-0067"> <h4 class="title">Allocation</h4> <p>In only three of the eight trials (<a href="./references#CD010225-bbs2-0002" title="CinarO , PiratA , ZeynelogluP , BayraktarN , ArslanG . Hemodynamic and metabolic responses to ketamine and etomidate sedations during endotracheal intubation in critically ill patients. Critical Care Medicine. Conference: 40th Critical Care Congress of the Society of Critical Care Medicine San Diego, CA United States. San Diego, CA United States, 2010; Vol. 38 (12 Suppl). ">Cinar 2010</a>; <a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>) were the healthcare worker(s) administering the experimental treatment blinded. In two trials (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>; <a href="./references#CD010225-bbs2-0006" title="KoksalG . The effect of single dose of etomidate used during emergency intubation on hemodynamics and adrenal cortex. Unpublished manuscript N/A. ">Koksal 2013</a>) it is unclear, whereas in one trial (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>), despite there being an appropriate randomization process in place, the physicians administering the study medication were unblinded. This raised significant concerns as unblinded healthcare workers with preconceived beliefs about the safety and efficacy of the study drugs may have altered the randomization sequence. The concealment methodology utilized would make it unlikely that the allocation sequence of the participants could have been altered. <a href="./references#CD010225-bbs2-0002" title="CinarO , PiratA , ZeynelogluP , BayraktarN , ArslanG . Hemodynamic and metabolic responses to ketamine and etomidate sedations during endotracheal intubation in critically ill patients. Critical Care Medicine. Conference: 40th Critical Care Congress of the Society of Critical Care Medicine San Diego, CA United States. San Diego, CA United States, 2010; Vol. 38 (12 Suppl). ">Cinar 2010</a> described their methodology as a "prospective, randomized, double blinded study", but did not elaborate on their methods of sequence generation or concealment. This was likely adequate, but the risk of bias remained unclear in the absence of this description. </p> </section> <section id="CD010225-sec-0068"> <h4 class="title">Blinding</h4> <p>In three of the eight trials (<a href="./references#CD010225-bbs2-0002" title="CinarO , PiratA , ZeynelogluP , BayraktarN , ArslanG . Hemodynamic and metabolic responses to ketamine and etomidate sedations during endotracheal intubation in critically ill patients. Critical Care Medicine. Conference: 40th Critical Care Congress of the Society of Critical Care Medicine San Diego, CA United States. San Diego, CA United States, 2010; Vol. 38 (12 Suppl). ">Cinar 2010</a>; <a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>) the healthcare worker(s) administering the experimental treatment were blinded. In one trial (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>), although the workers administering the study drug were unblinded, the teams providing all subsequent care were blinded to treatment allocation. It was unclear to what degree knowledge of treatment allocation may have altered patient care. An obvious possibility was the administration of steroids to patients who received etomidate. Differences in fluid resuscitation, administration of vasoactive medications, or other critical care unit treatments were unlikely but cannot be ruled out. </p> <p>Virtually all eight included trials' outcomes were objective (ACTH stimulation test results, serum cortisol levels, mortality, etc) and the trials (<a href="./references#CD010225-bbs2-0002" title="CinarO , PiratA , ZeynelogluP , BayraktarN , ArslanG . Hemodynamic and metabolic responses to ketamine and etomidate sedations during endotracheal intubation in critically ill patients. Critical Care Medicine. Conference: 40th Critical Care Congress of the Society of Critical Care Medicine San Diego, CA United States. San Diego, CA United States, 2010; Vol. 38 (12 Suppl). ">Cinar 2010</a>; <a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>) that did use more subjective outcomes (ease of intubation, vocal cord visualization, etc.) blinded the assessors. On this basis, detection bias was not a concern when interpreting the conclusions from this review. </p> </section> <section id="CD010225-sec-0069"> <h4 class="title">Incomplete outcome data</h4> <p>One of the advantages of critical care research is the ability to obtain excellent patient follow‐up (as patients are intubated and ventilated). Yet, many of these trials are threatened by the significant proportions of patients lost to follow‐up. In one unblinded trial (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>) over 50% of eligible patients were not enrolled (a significant proportion of which were because of "protocol violations"), and no additional explanation was provided. In one trial (<a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>), close to 20% of enrolled patients were lost to follow‐up. In another trial (<a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>), 9/31 patients were excluded. </p> <p>In two of the larger trials (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>), follow‐up was excellent with only two patients lost to follow‐up. One of the smaller trials (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>) also had very good follow‐up, with only one patient lost to follow‐up. </p> <p>In six of the eight trials, follow‐up was either poor or not described. Fortunately the large trials did demonstrate excellent followup, thereby reducing concern about attrition bias. </p> </section> <section id="CD010225-sec-0070"> <h4 class="title">Selective reporting</h4> <p>In the current controversy regarding the haemodynamic effect of etomidate, the adrenal suppression, and ultimately any effect it may or may not have on mortality, any finding is noteworthy and publishable. It was unlikely that negative studies would not be submitted for publication (and we did not identify any examples of this during our handsearch of conference abstracts), or that negative findings within a study (so‐called within study reporting bias) would not be described. </p> </section> <section id="CD010225-sec-0071"> <h4 class="title">Other potential sources of bias</h4> <p>Designing a trial to compare single‐dose etomidate to another agent(s) is fraught with challenges. The heterogeneity of the patient populations that require emergency intubation, managing informed consent for an emergent treatment, and blinding the healthcare team to medications that require emergent dose titration are impediments to bias free studies. </p> <p>Another important source of bias is the characteristics of the study population. The concern of negative consequences from adrenal suppression is widely believed to be most important in critically ill patients in shock, particularly those with sepsis. In one recent trial (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>), the majority of patients were intubated for airway protection due to neurologic compromise. It was not surprising that etomidate‐induced adrenal suppression did not affect SOFA score as these patients were neither septic nor in shock. </p> </section> </section> <section id="CD010225-sec-0072"> <h3 class="title" id="CD010225-sec-0072">Effects of interventions</h3> <p>See: <a href="./full#CD010225-tbl-0001"><b>Summary of findings for the main comparison</b> Etomidate versus all other induction agents for endotracheal intubation in critically ill patients</a> </p> <section id="CD010225-sec-0073"> <h4 class="title">Primary outcome: mortality</h4> <p>None of the included studies reported mortality as their primary outcome, and none were powered to detect a mortality difference. No individual trial showed a significant difference in mortality. There was no statistical heterogeneity in this comparison (Tau² = 0.00; Chi² = 2.80, df = 5 (P = 0.73); I² = 0%). We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. The pooled result of 390 patients receiving etomidate, compared to 382 patients receiving other induction agents, showed no difference in mortality (OR 1.17; 95% CI 0.86 to 1.60) (see <a href="./references#CD010225-fig-0004" title="">Analysis 1.1</a>). </p> <p>We performed a subgroup analysis comparing etomidate to individual comparator agents. Only one study (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>) compared etomidate to thiopentone. We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. When 17 patients receiving etomidate were compared to 17 patients receiving thiopentone, there was no significant difference in mortality (OR 1.94; 95% CI 0.38 to 9.88). Four studies compared etomidate to midazolam (with or without fentanyl) (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>; <a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>, <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>). There was no statistical heterogeneity in this comparison (Tau² = 0.00; Chi² = 2.28, df = 3 (P = 0.52); I² = 0%). We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. The pooled result of 139 patients receiving etomidate, compared to 130 patients receiving midazolam, showed no difference in mortality (OR 1.06; 95% CI 0.61 to 1.83). Only one study (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>) compared etomidate to ketamine. We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. When 234 patients receiving etomidate were compared to 235 patients receiving ketamine, there was no statistically significant difference in mortality (OR 1.20; 95% CI 0.81 to 1.76) (see <a href="./references#CD010225-fig-0005" title="">Analysis 1.2</a>). </p> <p>We performed a subgroup analysis comparing the effects of etomidate on different etiologies of critical illness. Only one study (<a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>) studied etomidate specifically in patients with septic shock. We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. When 61 septic patients receiving etomidate were compared to 59 septic patients receiving other agents, there was no significant difference in mortality (OR 1.34; 95% CI 0.64 to 2.81). Only one study (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>) studied etomidate specifically in traumatized patients. We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. When 18 trauma patients receiving etomidate were compared to 12 trauma patients receiving other agents, there was no statistically significant difference in mortality (OR 3.79; 95% CI 0.17 to 86.13). No studies involving patients in cardiogenic shock were identified. Four studies reported results for patients with undifferentiated, or unreported, etiologies of critical illness (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>; <a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>; <a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>). There was no statistical heterogeneity in this comparison (Tau² = 0.00; Chi² = 2.07, df = 3 (P = 0.56); I² = 0%). We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. The pooled result of 311 undifferentiated patients receiving etomidate, compared to 311 undifferentiated patients receiving other induction agents, showed no difference in mortality (OR 1.12; 95% CI 0.79 to 1.58) (see <a href="./references#CD010225-fig-0006" title="">Analysis 1.3</a>). </p> <p>Only two studies were judged to be at low risk of bias (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>). We analysed mortality when only these two studies were included. There was no statistical heterogeneity in this comparison (Tau² = 0.00; Chi² = 0.07, df = 1 (P = 0.79); I² = 0%). We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. The pooled result of 295 patients receiving etomidate, compared to 294 patients receiving other induction agents, showed no difference in mortality (OR 1.23; 95% CI 0.87 to 1.73) (see <a href="./references#CD010225-fig-0007" title="">Analysis 1.4</a>). </p> <p>Due to a large proportion of patients lost to follow‐up, we performed a post hoc sensitivity analysis where all missing patients were assumed to have died. There was no statistical heterogeneity in this comparison (Tau² = 0.00; Chi² = 2.64, df = 5 (P = 0.76); I² = 0%). We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. The pooled result of 425 patients receiving etomidate, compared to 408 patients receiving other induction agents, showed no difference in mortality (OR 1.15; 95% CI 0.86 to 1.53) (see <a href="./references#CD010225-fig-0008" title="">Analysis 1.5</a>). </p> <p>The 30 day mortality data were not available. We reported mortality data at the individual study conclusion. </p> </section> <section id="CD010225-sec-0074"> <h4 class="title">Secondary outcomes</h4> <section id="CD010225-sec-0075"> <h5 class="title">ACTH stimulation test</h5> <p>Four studies reported dichotomous data regarding ACTH stimulation tests (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>; <a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>). ACTH stimulation tests were considered to be positive or negative according to standardized criteria (<a href="./references#CD010225-bbs2-0041" title="MarikPE , PastoresSM , AnnaneD , MeduriGU , SprungCL , ArltW , et al. American College of Critical Care Medicine. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Critical Care Medicine2008;36(6):1937‐49. [MEDLINE: 18496365] ">Marik 2008</a>). There was some statistical heterogeneity in this comparison (Tau² = 0.42; Chi² = 6.55, df = 4 (P = 0.16); I² = 39%). We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. No studies reported the results of ACTH stimulation tests performed less than four hours after receiving etomidate, or the comparator. Two studies (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>) reported the results of ACTH stimulation tests performed between four and six hours after induction. There was no statistical heterogeneity in this comparison (Tau² = 0.00; Chi² = 0.20, df = 1 (P = 0.66); I² = 0%). We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. The pooled result of 28 patients receiving etomidate, compared to 20 patients receiving other induction agents, showed a significant difference in the proportion of positive ACTH stimulation tests (OR 19.98; 95% CI 3.95 to 101.11). Only one study (<a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>) reported ACTH stimulation test results performed between 6 and 12 hours post‐induction. None of the patients in either treatment arm demonstrated a positive ACTH stimulation test (n etomidate = 7, n other = 7), so the treatment effect could not be estimated. Three studies (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>; <a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>) reported results of ACTH stimulation tests performed more than 12 hours after induction. There was no statistical heterogeneity in this comparison (Tau² = 0.00; Chi² = 0.03, df = 2 (P = 0.99); I² = 0%). We employed a random‐effects model for meta‐analysis, describing the OR and 95% CI. The pooled result of 260 patients receiving etomidate, compared to 259 patients receiving other induction agents, showed a significant difference in the proportion of positive ACTH stimulation tests (OR 2.37; 95% CI 1.61 to 3.47) (see <a href="./references#CD010225-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD010225-sec-0076"> <h5 class="title">Random serum cortisol levels</h5> <p>Three studies (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>; <a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0006" title="KoksalG . The effect of single dose of etomidate used during emergency intubation on hemodynamics and adrenal cortex. Unpublished manuscript N/A. ">Koksal 2013</a>) reported continuous data regarding random serum cortisol levels. There was statistical heterogeneity in this comparison (Tau² = 2.38; Chi² = 4.46, df = 3 (P = 0.22); I² = 33%). We employed a random‐effects model for meta‐analysis, describing the MD and 95% CI. The pooled result of 75 patients receiving etomidate, compared to 70 patients receiving other induction agents, showed a significant difference in the random serum cortisol level (MD ‐4.96; 95% CI ‐8.06 to ‐1.86) (see <a href="./references#CD010225-fig-0010" title="">Analysis 1.7</a>). For Analysis 1.7.2 and Analysis 1.7.4, the sample sizes in the <a href="./references#CD010225-bbs2-0006" title="KoksalG . The effect of single dose of etomidate used during emergency intubation on hemodynamics and adrenal cortex. Unpublished manuscript N/A. ">Koksal 2013</a> paper were adjusted from 20 to 10 in each of the treatment and control groups in order to avoid double counting the sample size in the overall estimate of effect. The mean and SD values were left unchanged. </p> </section> <section id="CD010225-sec-0077"> <h5 class="title">SOFA score</h5> <p>One study (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>) reported the effects of etomidate on SOFA score. Statistical heterogeneity was not calculated. We employed a random‐effects model for meta‐analysis, describing the MD and 95% CI. The pooled result of 234 patients receiving etomidate, compared to 235 patients receiving other induction agents, showed a significant difference in the SOFA score (MD 0.70; 95% CI 0.01 to 1.39) favouring other induction agents over etomidate (see <a href="./references#CD010225-fig-0011" title="">Analysis 1.8</a>). </p> </section> <section id="CD010225-sec-0078"> <h5 class="title">ICU length of stay (LOS)</h5> <p>Three studies (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>) reported the effects of etomidate on ICU LOS. There was significant statistical heterogeneity in this comparison (Tau² = 8.82; Chi² = 12.89, df = 2 (P = 0.002); I² = 84%). We employed a random‐effects model for meta‐analysis, describing the MD and 95% CI. The pooled result of 315 patients receiving etomidate, compared to 306 patients receiving other induction agents, showed no significant difference in ICU LOS (MD 1.70; 95% CI ‐2.00 to 5.40) (see <a href="./references#CD010225-fig-0012" title="">Analysis 1.9</a>). </p> </section> <section id="CD010225-sec-0079"> <h5 class="title">Hosptial length of stay (LOS)</h5> <p>Two studies (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>) reported the effects of etomidate on hospital LOS. There was significant statistical heterogeneity in this comparison (Tau² = 42.71; Chi² = 10.85, df = 1 (P = 0.0010); I² = 91%). We employed a random‐effects model for meta‐analysis, describing the MD and 95% CI. The pooled result of 81 patients receiving etomidate, compared to 71 patients receiving other induction agents, showed no statistically significant difference in hospital LOS (MD 2.41; 95% CI ‐7.08 to 11.91) (see <a href="./references#CD010225-fig-0013" title="">Analysis 1.10</a>). </p> </section> <section id="CD010225-sec-0080"> <h5 class="title">Duration of mechanical ventilation</h5> <p>Three studies (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>) reported the effects of etomidate on duration of mechanical ventilation. There was significant statistical heterogeneity in this comparison (Tau² = 9.59; Chi² = 14.75, df = 2 (P = 0.0006); I² = 86%). We employed a random‐effects model for meta‐analysis, describing the MD and 95% CI. The pooled result of 315 patients receiving etomidate, compared to 306 patients receiving other induction agents, showed no significant difference in the duration of mechanical ventilation (MD 2.14; 95% CI ‐1.67 to 5.95) (see <a href="./references#CD010225-fig-0014" title="">Analysis 1.11</a>). </p> </section> <section id="CD010225-sec-0081"> <h5 class="title">Duration of vasopressor support</h5> <p>Only one study (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>} reported the effects of etomidate on the duration of vasopressor support. We employed a random‐effects model for meta‐analysis, describing the MD and 95% CI. The pooled result of 234 patients receiving etomidate, compared to 235 patients receiving other induction agents, showed no significant difference in the duration of vasopressor support (MD 1.00; 95% CI ‐0.53 to 2.53) (see <a href="./references#CD010225-fig-0015" title="">Analysis 1.12</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010225-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010225-sec-0082"></div> <section id="CD010225-sec-0083"> <h3 class="title" id="CD010225-sec-0083">Summary of main results</h3> <section id="CD010225-sec-0084"> <h4 class="title">There are insufficient data to conclude that etomidate use is associated with an increased risk of harm, or to conclude that it is safe. </h4> </section> <section id="CD010225-sec-0085"> <h4 class="title">Mortality</h4> <p>A non‐significant trend towards increased mortality was observed. Overall, no strong evidence exists to suggest that etomidate, when compared to other bolus dose induction agents, increases mortality in critically ill patients (OR 1.17; 95% CI 0.86 to 1.60). </p> <p>No strong evidence exists to suggest that etomidate increases mortality when compared to thiopentone (OR 1.94; 95% CI 0.38 to 9.88), midazolam with or without fentanyl (OR 1.06; 95% CI 0.61 to 1.83), or ketamine (OR 1.20; 95% CI 0.81 to 1.76). </p> <p>No strong evidence exists to suggest that etomidate increases mortality in the subset of critically ill patients with septic shock (OR 1.34; 95% CI 0.64 to 2.81), trauma (OR 3.79; 95% CI 0.17 to 86.13), cardiogenic shock (no data), or undifferentiated critical illness (OR 1.12; 95% CI 0.79 to 1.58). </p> <p>This lack of strong evidence for increased mortality due to the use of etomidate remains when only studies judged to be at low risk of bias are included in the analysis (OR 1.23; 95% CI 0.87 to 1.73). Due to a large number of participants lost to follow‐up, we performed a post hoc sensitivity analysis where all patients lost to follow up were assumed to have died. Also, in this scenario no strong evidence of increased mortality associated with etomidate use was identified (OR 1.15; 95% CI 0.86 to 1.53). </p> <p>Therefore, with the existing evidence to date, despite a trend towards harm, etomidate use does not seem to cause an increase in mortality when used for emergency endotracheal intubation in patients with critical illness. This evidence is of moderate quality. </p> </section> <section id="CD010225-sec-0086"> <h4 class="title">Adrenal function</h4> <p>Overall, strong evidence of moderate quality suggests that the use of etomidate in critically ill patients increases the likelihood of a positive ACTH stimulation test, and this difference is greater at four to six hours (OR 19.98; 95% CI 3.95 to 101.11) than after 12 hours post‐induction (OR 2.37; 95% CI 1.61 to 3.47). Likewise, the use of etomidate in critically ill patients appears to be associated with statistically significant reductions in random serum cortisol levels (MD ‐4.96; 95% CI ‐8.06 to ‐1.86). Again, this difference is more pronounced at four to six hours (MD ‐5.73; 95% CI ‐10.24 to ‐1.23) after induction compared to greater than 12 hours (MD ‐3.78; 95% CI ‐10.01 to 2.44) when it is no longer statistically significant. This evidence is of moderate quality. </p> </section> <section id="CD010225-sec-0087"> <h4 class="title">Organ system dysfunction (SOFA score)</h4> <p>The use of etomidate in critically ill patients is associated with a statistically significant increase in SOFA score, indicating a higher risk of multi‐system organ failure when compared to other induction agents (MD 0.70; 95% CI 0.01 to 1.39). This evidence is of high quality. It should be noted that Jabre (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>) concluded that no difference in SOFA score could be attributed to the use of etomidate, while we have concluded that a difference does exist. This is due to the fact that <a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a> utilized one decimal place in their data analysis and concluded that the mean difference in SOFA score of 0·7 (95% CI 0·0 to 1·4) was insignificant because the confidence interval included 0.0. When the raw data were entered into RevMan for analysis, data were calculated to the second decimal place, which reached statistical significance because the lower confidence interval was 0.01. The SOFA score is a numerical surrogate score for organ system dysfunction that ranges from 0 (good organ function) to 24 (worse organ function). The difference in the maximum SOFA score in the etomidate group was 10.3 compared to 9.6 in the ketamine group, with a difference of 0.7 between groups (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>). Regardless of whether this difference was statistically significant it is not clinically meaningful. </p> </section> <section id="CD010225-sec-0088"> <h4 class="title">Health services utilization</h4> <p>Non‐significant trends towards increased health services utilization were observed. However, when compared to other induction agents, no strong evidence exists to suggest that etomidate increases ICU length of stay (MD 1.70; 95% CI ‐2.00 to 5.40), hospital length of stay (MD 2.41; 95% CI ‐7.08 to 11.91), duration of mechanical ventilation (MD 2.14; 95% CI ‐1.67 to 5.95), or duration of vasopressor use (MD 1.00; 95% CI ‐0.53 to 2.53). This evidence is of moderate quality. </p> </section> </section> <section id="CD010225-sec-0089"> <h3 class="title" id="CD010225-sec-0089">Overall completeness and applicability of evidence</h3> <p>We searched for randomized trials that compared etomidate to another induction agent or a combination of agents for endotracheal intubation of critically ill patients. We identified only seven published papers and one unpublished paper. For an agent as commonly used as etomidate this is a very small number of studies. Despite this small number of studies we are confident that all eligible reports were identified. The total number of patients from all studies was only 772. </p> <p>In the largest trial included in our analysis (<a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>) 69% of patients in both arms were intubated for being comatose, while the minority were intubated for 'shock', 'acute respiratory failure', or 'other' reasons. These obtunded patients (n = 324) account for 42% of all patients in our review. Although it is accepted that patients obtunded secondary to intracranial catastrophes and drug intoxications are critically ill, this is not the group most likely to benefit from the haemodynamic stability inherent in etomidate use, nor are they the patients most at risk from its potential negative downstream effects of adrenal suppression. Applying conclusions from a small trial with a high preponderance of obtunded patients to patients in shock should be done with caution. Larger studies of patients in shock are still required to assess the appropriateness of etomidate's use. </p> <p>Each of the individual trials included in our review had point estimates of effect suggesting increased mortality with the use of etomidate, but none were powered sufficiently to detect a difference. All confidence intervals crossed the line of no effect. The fact that all of the studies, and our pooled estimate, cross the line of no effect is likely because all studies were underpowered. It is possible that with more studies the 95% confidence intervals will no longer cross the line of no effect. </p> </section> <section id="CD010225-sec-0090"> <h3 class="title" id="CD010225-sec-0090">Quality of the evidence</h3> <p>Using the principals of the GRADE system, the quality of the data from randomized controlled trials (with the exception of SOFA score) were downgraded to 'moderate'. This is due mainly to methodological limitations and the high proportions of patients lost to follow‐up in the smaller studies (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>; <a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>; <a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>). Other methodological limitations involving randomization and allocation concealment supported this downgrade as well. In particular, the authors of one study did not describe their sequence generation or concealment (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>); another unblinded study (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>) only enrolled half of the eligible patients, with almost half of the excluded patients excluded due to 'protocol violations'. A third study (<a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>) was unblinded and did not describe their allocation concealment procedures. In addition, one third of the patients in this unblinded study were excluded from the analysis, raising a significant concern in relation to bias (<a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>). </p> <p>We did not downgrade our quality of evidence based on directness as all trials directly compared etomidate to a comparator agent in directly generalizable populations. </p> <p>We did not downgrade our quality of evidence based on heterogeneity or inconsistency as we demonstrated very little statistical heterogeneity, and all studies reported similar results. There were differences in the overall mortality rates reported within the studies, which may suggest clinical heterogeneity. Most studies reported an overall mortality rate of 23% to 38% (<a href="./references#CD010225-bbs2-0001" title="AbsalomA , PledgerD , KongA . Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia1999;54(9):861‐7. [PUBMED: 10460557] AbsalomAR , PledgerDR , KongA . Effects of a single dose of etomidate on adreno‐cortical function in the critically ill. British Journal of Anaesthesia1997;79 (5):679P. ">Absalom 1999</a>; <a href="./references#CD010225-bbs2-0004" title="JabreP , CombesX , LapostolleF , DhaouadiM , Ricard‐HibonA , VivienB , et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet2009;374(9686):293‐300. [PUBMED: 19573904] ">Jabre 2009</a>; <a href="./references#CD010225-bbs2-0005" title="JacobyJ , HellerM , NicholasJ , PatelN , CestaM , SmithG , et al. Etomidate Versus Midazolam for Out‐of‐Hospital Intubation: A Prospective, Randomized Trial. Annals of Emergency Medicine2006;47(6):525‐30. [PUBMED: 16713778] JacobyJL , CestaM , McGeeJ , HellerMB , ReedJ . Etomidate versus midazolam for out‐of hospital Intubation: A prospective randomized trial ‐ Abstract 175 ACEP Research Forum 2003. Annals Of Emergency Medicine2003;42(4):S48. ">Jacoby 2006</a>; <a href="./references#CD010225-bbs2-0008" title="TekwaniK , WattsH , SweisR , RzechulaK , KulstadE . The effect of etomidate on hospital length of stay of patients with sepsis: A prospective, randomized study: Conference: American College of Emergency Physicians, ACEP 2009 Research Forum. Annals of Emergency Medicine2009;54(3):S4. TekwaniKL , WattsHF , SweisRT , RzechulaKH , KulstadEB . A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Annals of Emergency Medicine2010;56(5):481‐9. [PUBMED: 20828877] ">Tekwani 2010</a>), however two studies reported overall mortality rates of 3% (<a href="./references#CD010225-bbs2-0007" title="SchenartsCL , BurtonJH , RikerRR . Adrenocortical dysfunction following etomidate induction in emergency department patients. Academic Emergency Medicine2001;8(1):1‐7. [PUBMED: 11136139] SchenartsCL , RikerRR . 1999 SAEM Annual Meeting abstracts. Abstract 449: Adrenocortical dysfunction following etomidate induction in emergency department. Academic Emergency Medicine1999;6(5):520. ">Schenarts 2001</a>) and 7% (<a href="./references#CD010225-bbs2-0003" title="HildrethAN , MejiaVA , MaxwellRA , SmithPW , DartBW , BarkerDE . Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. Journal of Trauma Injury, Infection, and Critical Care2008;65(3):573‐8. [PUBMED: 18784570] ">Hildreth 2008</a>). </p> <p>We did not downgrade our quality of evidence based on imprecision as the reported confidence intervals were sufficiently narrow. </p> <p>We did not downgrade our quality of evidence based on the potential for publication bias. While we did not employ a funnel plot (we did not identify 10 studies for inclusion), all studies reported similar findings and the risk of publication bias was judged to be low. </p> </section> <section id="CD010225-sec-0091"> <h3 class="title" id="CD010225-sec-0091">Potential biases in the review process</h3> <p>We believe that our search methodology was sufficient to minimize the chances that any study was missed. We did not employ a funnel plot because fewer than 10 studies were included in our analysis. We believe that our three investigator, data abstraction process also minimized the chances for individual beliefs to influence our results. Some of our statistical analysis has led to transformed data. Specifically, we were unable to enter non‐normally distributed data into RevMan as they were reported as medians and IQRs. Instead, we replicated the data transformation process of other investigators (<a href="./references#CD010225-bbs2-0049" title="ZachariasM , MugawarM , HerbisonGP , WalkerRJ , HovhannisyanK , SivalingamP , ConlonNP . Interventions for protecting renal function in the perioperative period. Cochrane Database of Systematic Reviews2013, Issue 9. [DOI: 10.1002/14651858.CD003590.pub4] ">Zacharias 2013</a>) and roughly transformed these data into means and standard deviations. While all data were transformed in the same manner, the exact precision of the results may be altered by this process. If future editions of RevMan allow median and IQR data to be analysed primarily, we will report the data as such in future review updates. This data transformation affects data regarding hospital and ICU length of stay, duration of ventilator support, and duration of vasopressor support. It does not affect data on adrenal gland dysfunction or mortality. </p> </section> <section id="CD010225-sec-0092"> <h3 class="title" id="CD010225-sec-0092">Agreements and disagreements with other studies or reviews</h3> <p>Three other systematic reviews have been published on the topic of etomidate use in critically ill patients. Our results were similar to Hohl et al, where the pooled data were from seven studies examining the effects of etomidate in critically ill patients. None of the individual studies were powered to detect a mortality difference, and a pooled odds ratio estimate of mortality showed no statistical difference (<a href="./references#CD010225-bbs2-0039" title="HohlCM , Kelly‐SmithCH , YeungTC , SweetDD , Doyle‐WatersMM , SchulzerM . The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: a systematic review. Annals of Emergency Medicine2010;56:105‐13. [PUBMED: 20346542] ">Hohl 2010</a>). </p> <p>Albert et al published a systematic review of 19 etomidate trials (<a href="./references#CD010225-bbs2-0029" title="AlbertSG , AriyanS , RatherA . The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Medicine2011;37(6):901‐10. [PUBMED: 21373823] ">Albert 2011</a>). The authors concluded that strong evidence exists for an increased relative risk for etomidate‐induced adrenal suppression. They also stated that weak evidence exists for any association between etomidate and mortality. The authors very correctly assert that the mortality conclusions are weak based on "a preponderance of non‐randomized trials and heterogeneity of studies". In their review, Albert et al combined clinically heterogeneous data from 15 retrospective, observational, and non‐randomized trials with four prospective randomized trials. Conclusions drawn from combining such heterogeneous trials should be interpreted with caution. </p> <p>Chan and colleagues also published a meta‐analysis of randomized controlled trials and observational studies examining the effects of etomidate on adrenal insufficiency and all‐cause mortality in septic patients. In this meta‐analysis, they reported a pooled relative risk of 1.20 (95% CI 1.02 to 1.42) for mortality, and a pooled relative risk of 1.33 (95% CI 1.22 to 1.46) for the development of adrenal insufficiency (<a href="./references#CD010225-bbs2-0032" title="ChanCM , MitchellAL , ShorrAF . Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta‐analysis. Critical Care Medicine2012;40(11):2945‐53. [PUBMED: 22971586] ">Chan 2012</a>). The combination of observational and randomized data may be subject to bias and the results must be interpreted appropriately. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010225-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010225-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010225-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010225-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 1 Mortality: Data as reported." data-id="CD010225-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 1 Mortality: Data as reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 2 Mortality: Data as reported ‐ Subgroup analysis of comparator drugs." data-id="CD010225-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 2 Mortality: Data as reported ‐ Subgroup analysis of comparator drugs. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 3 Mortality: Data as reported ‐ Subgroup analysis of etiology of shock." data-id="CD010225-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 3 Mortality: Data as reported ‐ Subgroup analysis of etiology of shock. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 4 Mortality: Data as reported ‐ Studies judged to be at low risk of bias." data-id="CD010225-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 4 Mortality: Data as reported ‐ Studies judged to be at low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 5 Mortality: Post Hoc ITT Analysis accounting for missing subjects." data-id="CD010225-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 5 Mortality: Post Hoc ITT Analysis accounting for missing subjects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 6 ACTH Stimulation Test." data-id="CD010225-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 6 ACTH Stimulation Test. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 7 Random Serum Cortisol levels (μg/dL) after receiving intervention." data-id="CD010225-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 7 Random Serum Cortisol levels (μg/dL) after receiving intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 8 Organ System Dysfunction (SOFA Score)." data-id="CD010225-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 8 Organ System Dysfunction (SOFA Score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 9 ICU Length of Stay." data-id="CD010225-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 9 ICU Length of Stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 10 Hospital Length of Stay." data-id="CD010225-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 10 Hospital Length of Stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 11 Duration of Mechanical Ventilation." data-id="CD010225-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 11 Duration of Mechanical Ventilation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010225-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/urn:x-wiley:14651858:media:CD010225:CD010225-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_t/tCD010225-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Etomidate versus all other induction agents, Outcome 12 Duration of Vasopressor Support." data-id="CD010225-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Etomidate versus all other induction agents, Outcome 12 Duration of Vasopressor Support. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/media/CDSR/CD010225/image_n/nCD010225-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010225-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Etomidate versus all other induction agents for endotracheal intubation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Etomidate versus all other induction agents for endotracheal intubation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with endotracheal intubation in critically ill patients<br/> <b>Settings:</b> <br/> <b>Intervention:</b> etomidate versus all other induction agents </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Etomidate versus all other induction agents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.17</b> <br/> (0.86 to 1.6) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>772<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>296 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>330 per 1000</b><br/> (265 to 402) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>241 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>271 per 1000</b><br/> (214 to 337) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>ACTH stimulation test</b> <br/> ACTH stimulation test is considered positive if the change in serum cortisol level was less than 9 μg/dL (248 nmol/L) after the administration of 250 μg of cosyntropin<br/> Follow‐up: 24 hours </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 2.37</b> <br/> (1.61 to 3.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>519<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>228 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>411 per 1000</b><br/> (322 to 506) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>322 per 1000</b><br/> (244 to 410) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Random serum cortisol levels (μg/dL) after receiving intervention</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean random serum cortisol levels (μg/dl) after receiving intervention in the control groups was<br/> <b>21 to 28 µg/dL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean random serum cortisol levels (μg/dl) after receiving intervention in the intervention groups was<br/> <b>4.96 lower</b><br/> (8.06 to 1.86 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Organ system dysfunction</b><br/> Sequential Organ Failure Assessment (SOFA) Score. Scale from: 1 to 24 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean organ system dysfunction in the control groups was<br/> <b>9.6</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean organ system dysfunction in the intervention groups was<br/> <b>0.7 higher</b><br/> (0.01 to 1.39 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>469<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>ICU length of stay (days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ICU length of stay (days) in the control groups was<br/> <b>3 to 22 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ICU length of stay (days) in the intervention groups was<br/> <b>1.7 higher</b><br/> (2 lower to 5.4 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>621<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Hospital length of stay (days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean hospital length of stay (days) in the control groups was<br/> <b>6.4 to 10 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean hospital length of stay (days) in the intervention groups was<br/> <b>2.41 higher</b><br/> (7.08 lower to 11.91 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of mechanical ventilation (days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of mechanical ventilation (days) in the control groups was<br/> <b>1.5 to 13 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of mechanical ventilation (days) in the intervention groups was<br/> <b>2.14 higher</b><br/> (1.67 lower to 5.95 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>621<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> A significant number of patients were lost to follow‐up </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Etomidate versus all other induction agents for endotracheal intubation in critically ill patients</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/full#CD010225-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010225-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Etomidate versus all other induction agents</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality: Data as reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>772</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.86, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mortality: Data as reported ‐ Subgroup analysis of comparator drugs <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>772</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.86, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Studies comparing etomidate and Thiopentone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.94 [0.38, 9.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Studies comparing etomidate and midazolam (+/‐ fentanyl)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>269</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.61, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Studies comparing etomidate and ketamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.81, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality: Data as reported ‐ Subgroup analysis of etiology of shock <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>772</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.86, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Septic Shock</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.64, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Trauma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.79 [0.17, 86.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Cardiogenic Shock</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Undifferentiated Critical Illness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.79, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mortality: Data as reported ‐ Studies judged to be at low risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>589</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.87, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mortality: Post Hoc ITT Analysis accounting for missing subjects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>833</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.86, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 ACTH Stimulation Test <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 ACTH Stimulation test performed 4‐6 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.98 [3.95, 101.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 ACTH Stimulation Test Performed 6‐12 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 ACTH Stimulation test performed &gt;12h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>519</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.37 [1.61, 3.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Random Serum Cortisol levels (μg/dL) after receiving intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.96 [‐8.06, ‐1.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Random Serum Cortisol Levels 4‐6 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.73 [‐10.24, ‐1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Random Serum Cortisol Levels &gt;12h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.78 [‐10.01, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Organ System Dysfunction (SOFA Score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.01, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 ICU Length of Stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>621</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.00, 5.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Hospital Length of Stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.41 [‐7.08, 11.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Duration of Mechanical Ventilation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>621</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.14 [‐1.67, 5.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Duration of Vasopressor Support <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [‐0.53, 2.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Etomidate versus all other induction agents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010225.pub2/references#CD010225-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010225.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010225-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010225-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010225-note-0001">Français</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010225-note-0003">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010225\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010225\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010225\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010225\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010225\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010225.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010225.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010225.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010225.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010225.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724944593"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010225.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724944597"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010225.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e6f2aedd31bdf',t:'MTc0MDcyNDk0NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 